Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Pau, Riera"'
Autor:
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hector Corominas
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-10 (2023)
Abstract Background Sarilumab, an IL-6 receptor antagonist, is a first-line biologic disease-modifying anti-rheumatic drug for rheumatoid arthritis. The identification of genetic biomarkers as predictors of response to sarilumab could allow for a per
Externí odkaz:
https://doaj.org/article/0444fe7ddf56436ab6f8401650ec4da3
Autor:
Jan Thomas De Pourcq, Adria Riera, Laura Gras, Noe Garin, Maria Antònia Busquets, Joana Cardenete, Daniel Cardona, Pau Riera
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 896 (2024)
Ceftolozane-tazobactam (CT) is used for the treatment of complicated infections and for multidrug-resistant strains of Pseudomonas aeruginosa and extended-spectrum beta-lactamase-producing enterobacteria. In certain cases, simultaneous administration
Externí odkaz:
https://doaj.org/article/c2ff000b31cf46feb0f798deda850781
Autor:
Carmen Ligero, Pau Riera, Amine El-Amrani, Victor Bazan, José M. Guerra, Silvia Herraez, Xavier Viñolas, Josep M. Alegret
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 693 (2024)
Background: Amiodarone is an anti-arrhythmic drug that has extensive tissue distribution and substantial storage in the fat tissue. Different studies have described some implications of body fat composition in its pharmacokinetics and pharmacodynamic
Externí odkaz:
https://doaj.org/article/dc81064e7356433d9bbf52b7429a5ea6
Autor:
Joan Francesc Mir, Cristina Rodríguez-Caba, Maria Estrada-Campmany, Edurne Fernández de Gamarra-Martínez, Maria Antònia Mangues, Guillermo Bagaría, Pau Riera
Publikováno v:
Pharmacy, Vol 11, Iss 2, p 76 (2023)
The use of pharmacogenetics to optimize pharmacotherapy is growing rapidly. This study evaluates the feasibility and operability of a collaborative circuit involving hospital and community pharmacists to implement clopidogrel pharmacogenetics in Barc
Externí odkaz:
https://doaj.org/article/60626256647841ef98a90bc7bf72039e
Autor:
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Héctor Corominas
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1942 (2022)
Rheumatoid arthritis (RA) is a prevalent autoimmune disease characterized by chronic arthritis that may lead to irreversible joint damage and significant disability. Patients with RA are commonly treated with Tocilizumab (TCZ), an IL-6 receptor (IL-6
Externí odkaz:
https://doaj.org/article/c77ef964cf5745659f5d71f8609ecbda
Autor:
Miquel Roca, Antonio Riera-López del Amo, Pau Riera-Serra, Mª. Angeles Pérez-Ara, Adoración Castro, J. Roman Juan, Mauro García-Toro, Patricia García-Pazo, Margalida Gili
Publikováno v:
BMC Psychiatry, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Suicide is a serious public health concern. Depression is the main gateway to suicidal behavior. The already established relationship between depression and suicidal risk should now focus on the investigation of more specific fact
Externí odkaz:
https://doaj.org/article/1a15ce2be3ce416bbd9ba63fc8af4b53
Autor:
Pau Riera, Alícia Artigas-Baleri, Juliana Salazar, Ana Sebio, Anna C. Virgili, María Jesús Arranz, David Páez
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Irinotecan is widely used in the treatment of metastatic colorectal cancer (mCRC) despite its severe toxicities. Toxicity is often associated with the UGT1A1*28/*28 genotype. An explanation for idiopathic toxicity beyond the UGT1A1 biomarker, however
Externí odkaz:
https://doaj.org/article/ef87d544c8fd470cadea439b80e3e587
Autor:
Jan T. De Pourcq, Pau Riera
Publikováno v:
Nursing in Critical Care.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f3617f455fc918249e9df1bfb49e918
https://doi.org/10.1111/nicc.12910
https://doi.org/10.1111/nicc.12910
Autor:
Jordi Surrallés, Jordi Minguillón, Diego Arango, Juan A. Bueren, Thomas Helleday, Jordi Carreras-Puigvert, Adriana Lasa, Enrique Lerma, Alan González, Pau Riera, Carlos Carrascoso-Rubio, Rocío Nieto, Maria José Ramírez, Llorenç Rovirosa, José Antonio Casado, Águeda Martínez-Barriocanal, Helena Montanuy
Purpose:Fanconi anemia rare disease is characterized by bone marrow failure and a high predisposition to solid tumors, especially head and neck squamous cell carcinoma (HNSCC). Patients with Fanconi anemia with HNSCC are not eligible for conventional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee4ca94fce39854d8a8c19ce177befa
https://doi.org/10.1158/1078-0432.c.6528209.v1
https://doi.org/10.1158/1078-0432.c.6528209.v1
Autor:
Jordi Surrallés, Jordi Minguillón, Diego Arango, Juan A. Bueren, Thomas Helleday, Jordi Carreras-Puigvert, Adriana Lasa, Enrique Lerma, Alan González, Pau Riera, Carlos Carrascoso-Rubio, Rocío Nieto, Maria José Ramírez, Llorenç Rovirosa, José Antonio Casado, Águeda Martínez-Barriocanal, Helena Montanuy
Figure S5. FACS gating strategy to analyze white blood cell population in WT and Fanca-deficient mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19fb1da527d9bd30cf77bb72d47542ad
https://doi.org/10.1158/1078-0432.22472396.v1
https://doi.org/10.1158/1078-0432.22472396.v1